Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01324180
Title Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

non-Hodgkin lymphoma

acute lymphoblastic leukemia

Therapies

Metformin

Dexamethasone + Doxorubicin + Pegaspargase + Vincristine Sulfate

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.